fda approvals in fl and rcc, breakthrough designation in myeloma, and more
Published 6 years ago • 94 plays • Length 9:57
Download video MP4
Download video MP3
Similar videos
-
5:55
fda approval in myeloma, breakthrough designations in rcc and aplastic anemia, and more
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
8:00
fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
9:24
fda approvals in myeloma and head and neck cancer, and findings across several tumor types
-
6:56
fda approves tas-102, nivolumab breakthrough in rcc, two priority reviews, and more
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
8:29
fda approval in multiple myeloma, priority reviews in dlbcl and myeloma, and more
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
3:26
what does the fda approval of mrd testing for myeloma mean for patients and drug development?
-
1:34
dr. anderson on recent fda approvals in multiple myeloma
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
1:12
the recent fda approval of cilta-cel and its impact on myeloma patients in the uk
Clip.africa.com - Privacy-policy